Litcius/Paper detail

Letter: intestinal inflammation, COVID‐19 and gastrointestinal ACE2—exploring RAS inhibitors

Mayur Garg, Simon G. Royce, John Lubel

2020Alimentary Pharmacology & Therapeutics19 citationsDOIOpen Access PDF

Abstract

LINKED CONTENT This article is linked to Taxonera et al papers. To view these articles, visit https://doi.org/10.1111/apt.15804 and https://doi.org/10.1111/apt.15893 .

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)InflammationCoronavirus InfectionsBetacoronavirusMEDLINEGastroenterologyInternal medicineVirologyOutbreakBiologyDiseaseBiochemistryInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery Methods
Letter: intestinal inflammation, COVID‐19 and gastrointestinal ACE2—exploring RAS inhibitors | Litcius